Skip to main content
. 2020 Sep 18;11:570711. doi: 10.3389/fneur.2020.570711

Table 1.

Potential inhibitors of the Nlrp3 inflammasome.

Type Nlrp3-targeting Agent Tested in AD Neuroprotection Observed Sources
Direct Inhibitors Ginsenoside Rg3 N a (73, 90)
JC-124 Y Y (71)
Oridonin Y Y (91)
Tranilast N (75)
Indirect Inhibitors Ketone bodies (i.e., BHB) Y Y (92)
MCC950 N (80)
Glyburide N (82)
16673-43-0 N (79)
Autophagy-inducing Resveratrol N (86)
HU-308 N (85)
MicroRNAs miR-223 N (87)
miR-9 N (88)
a

Neuroprotection observations were not applicable in these studies.